EVETTE HEARN: Open Payments
NPI 1568549392 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 18 payments from 8 companies in 2025. Trend: 2023 $300 · 2024 $258 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 5 | $125 |
| Astellas Pharma US Inc | 4 | $89 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $41 |
| Averitas Pharma Inc. | 1 | $37 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $35 |
| Hologic Sales and Service, LLC | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: Leqembi, Veozah, MYFEMBREE, QUTENZA, APTIMA, Mirena, UBRELVY, QULIPTA.
Industry payments across FL — which companies pay providers there.
